Galapagos NV (GLPG): Price and Financial Metrics
GLPG Price/Volume Stats
| Current price | $28.77 | 52-week high | $45.21 |
| Prev. close | $29.45 | 52-week low | $28.76 |
| Day low | $28.76 | Volume | 141,100 |
| Day high | $29.37 | Avg. volume | 128,782 |
| 50-day MA | $33.64 | Dividend yield | N/A |
| 200-day MA | $36.92 | Market Cap | 1.90B |
GLPG Stock Price Chart Interactive Chart >
Galapagos NV (GLPG) Company Bio
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines in areas such as cystic fibrosis, inflammation, and other indications. The company was founded in 1999 and is Mechelen, Belgium.
Latest GLPG News From Around the Web
Below are the latest news stories about GALAPAGOS NV that investors may wish to consider to help them evaluate GLPG as an investment opportunity.
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301Mechelen, Belgium; 19 December 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the first patient has been dosed in PAPILIO-1, the Phase 1/2 study to evaluate the safety, efficacy, and feasibility of our seven-day vein-to-vein, point-of-care manufactured BCMA CAR-T candidate, GLPG5301, in adult patients with relapsed/refractory multiple myeloma (rrMM). This is Galapagos’ third oncology CAR-T program in clinical development. GLPG5301 is an autologous, second-generation |
GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023GLPG stock results show that Galapagos beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023. |
Best Momentum Stocks to Buy for December 13thGLPG, BBVA and TW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 13, 2023. |
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101Additional safety and efficacy data further support potential of innovative, decentralized approach to CAR-T manufacturing and transformational impact on patients with severe hematologic cancersTwo poster presentations include recent data updates and additional data not included in the ASH abstracts Galapagos to host a Key Opinion Leader (KOL) event with live webcast on Sunday, 10 December 2023 at 11:00 am PT/20:00 CET Mechelen, Belgium; 9 December 2023, 18:00 CET; Galapagos NV (Euronext & NASDA |
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023Mechelen, Belgium; 6 December 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will host a Key Opinion Leader (KOL) event during the 65th ASH Annual Meeting & Exposition in San Diego, CA, on Sunday, December 10, 2023, from 11:00 am PST to 12:30 pm PST. The in-person event will be held at the San Diego Marriott Gaslamp Quarter in the Presidio Ballroom B/C. To register as an in-person attendee, please click here. To register as a virtual attendee, please click here. |
GLPG Price Returns
| 1-mo | -12.05% |
| 3-mo | -24.62% |
| 6-mo | -9.73% |
| 1-year | -26.51% |
| 3-year | -65.48% |
| 5-year | -74.33% |
| YTD | -29.23% |
| 2023 | -8.40% |
| 2022 | -19.50% |
| 2021 | -44.30% |
| 2020 | -52.14% |
| 2019 | 125.45% |
Continue Researching GLPG
Want to see what other sources are saying about Galapagos Nv's financials and stock price? Try the links below:Galapagos Nv (GLPG) Stock Price | Nasdaq
Galapagos Nv (GLPG) Stock Quote, History and News - Yahoo Finance
Galapagos Nv (GLPG) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...